Medical Devices Japan

Japan Nuclear Medicine Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Japan Nuclear Medicine Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $904.0 Mn Placeholder estimate
Estimate 2025 $997.1 Mn 6.9% of the global market
Projected 2034 $2.41 Bn 141.6% Adds $1.41 Bn over 9 forecast years
CAGR 2025–2034 10.3% Faster than 60% of 193 Medical Devices markets here
Key players 6 +1
  • Japan is 6.87% of the global market.
  • In APAC, the largest is China at $1.28 Bn.
  • Fastest growing: India at 13.1% a year.
  • Japan ranks 2nd of 14 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.41 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Nuclear Medicine Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $904.0 Mn — —
2025 (base) $997.1 Mn +$93.1 Mn —
2026 (forecast) $1.10 Bn +$102.7 Mn +10.3%
2027 (forecast) $1.21 Bn +$113.3 Mn +21.7%
2028 (forecast) $1.34 Bn +$125.0 Mn +34.2%
2029 (forecast) $1.48 Bn +$137.8 Mn +48%
2030 (forecast) $1.63 Bn +$152.0 Mn +63.3%
2031 (forecast) $1.80 Bn +$167.7 Mn +80.1%
2032 (forecast) $1.98 Bn +$184.9 Mn +98.6%
2033 (forecast) $2.18 Bn +$204.0 Mn +119.1%
2034 (forecast) $2.41 Bn +$225.0 Mn +141.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Nuclear Medicine Market Analysis at a glance
Market size, 2025$997.1 Mn placeholder estimate
Forecast, 2034$2.41 Bn placeholder estimate
Growth (CAGR), 2025–203410.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersGE Healthcare, Siemens Healthineers, Lantheus Holdings, Cardinal Health, Curium and 1 more (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Nuclear Medicine Market Analysis Executive Summary

Nuclear medicine uses small amounts of radioactive tracers and special cameras to see how organs work and to treat some cancers.

Key segments of the nuclear medicine market include product (SPECT Systems, PET Systems and Diagnostic Radiotracers) and application (Oncology, Cardiology and Neurology).

Bar chart: Japan Nuclear Medicine market size, 2024–2034, placeholder estimates. $904.0 Mn in 2024, $997.1 Mn in 2025 and $2.41 Bn in 2034, 10.3% CAGR.
Japan Nuclear Medicine market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Nuclear Medicine Market Dynamics

Market Growth Drivers

More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the nuclear medicine market. Clinicians also use imaging earlier in care.

Opportunity

AI-assisted reading, compact systems for clinics and the replacement of old scanners give the nuclear medicine market room to grow.

Market Restraints

High equipment prices, a shortage of trained staff and long replacement cycles in public hospitals hold back the nuclear medicine market.

Competitive Landscape for Nuclear Medicine Market in Japan

The nuclear medicine market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Nuclear Medicine Market in Japan

Nuclear Medicine in Japan: rules and payment

Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare.⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how nuclear medicine products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Nuclear Medicine right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Nuclear Medicine in context

Japan compared

  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 17 countries we cover in APAC.[1]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 30.0% of people (2025). World: 10.4% of people (2025). Highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Inside Japan

Quick answers

Frequently asked questions

How big is the Nuclear Medicine market in Japan?
Placeholder estimate: about $997.1 Mn in 2025, rising to about $2.41 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Nuclear Medicine market in Japan growing?
Placeholder estimate: about 10.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Nuclear Medicine market report cover?
The report splits the market by product (SPECT Systems, PET Systems, Diagnostic Radiotracers, Therapeutic Radiopharmaceuticals), application (Oncology, Cardiology, Neurology, Thyroid Disease) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Nuclear Medicine market?
Key players include GE Healthcare, Siemens Healthineers, Lantheus Holdings, Cardinal Health, Curium and Bracco.
What is driving the Nuclear Medicine market?
More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the nuclear medicine market. Clinicians also use imaging earlier in care.
Who regulates Nuclear Medicine in Japan?
Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare. Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Japan

See all

Related on imaging and oncology

See the topic